Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Melanoma · Advanced Locoregional Melanoma · Metastatic Renal Cell Carcinoma · Clear Cell Histology

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • National Institutes of Health Clinical Center, Bethesda, Maryland, United States

    Contact: Study coordinator (NCI/Surgery Branch Recruitment Center) · irc@nih.gov · 866-820-4505
Study leads
  • Stephanie L Goff, M.D.

    Principal Investigator

    National Cancer Institute (NCI)